FDA
approval
· 2020-08-12
FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Civica, Inc.)
Summary
FDA approved Civica, Inc.'s supplemental application for norepinephrine bitartrate (ANDA 211359).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)